EntryPoint Capital’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,559
| Closed | -$446K | – | 751 |
|
|
2025
Q1 | $446K | Buy |
37,559
+23,454
| +166% | +$279K | 0.2% | 140 |
|
|
2024
Q4 | $266K | Buy |
+14,105
| New | +$266K | 0.11% | 445 |
|
|
2024
Q2 | – | Sell |
-8,335
| Closed | -$123K | – | 1387 |
|
|
2024
Q1 | $123K | Buy |
+8,335
| New | +$123K | 0.11% | 309 |
|